Indoco Remedies has acquired the manufacturing facility located at Baddi of Micro Labs, a Bangalore based company. The facility is spread over an area of 18000sq.mt, out of which 11,000sq.mt.is the built-up area. It produces 4.3 billion tablets and 50 million capsules p.a.
The acquired manufacturing site is close to the company’s existing manufacturing plant in Baddi, Himachal Pradesh. Baddi will thus be another manufacturing hub for the company’s solid dosages business in the regulated markets.
With this acquisition, Indoco will now have 6 facilities for finished dosages and 3 for active pharmaceutical ingredients (APIs). Out of these, 3 facilities for finished dosages, including sterile plant and 2 facilities for API manufacturing are USFDA approved.
Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.
